NDH.com

icon


Wolters Kluwer | Lippencott Williams & Wilkins
Clinical Pearls | Special Alerts
orange bar


   Web Toolkit
   Drug Updates

   Patient Teaching

   News Capsules

   Drug Warnings

   Herbal Spotlight

   Clinical Pearls
       Infusion Therapy
       Geriatric Considerations
       Special Alerts
       Medication Administration

   Nursing Links

   CE

   Career Opportunities

   Drug Info Bookstore

   Feedback

   Registration

   Disclaimer



naratriptan hydrochloride
Amerge

When used to treat migraine headaches, naratriptan may cause coronary artery vasospasm and increase the risk of cerebrovascular events. Thus, it's contraindicated in patients with signs or symptoms of, or a history of, cardiac ischemia or cerebrovascular or peripheral vascular syndromes.
     
   

Home - Guest Registry - Customer Service

Brought to you by Lippincott Williams & Wilkins.
For help on how you should use this site, see our
Disclaimer .

© Copyright 2008 by Lippincott Williams & Wilkins